OEM Vicolla Anti-Aging Vitamin C and Collagen Injection 0.5g

Product Name: OEM Vicolla Anti-Aging Vitamin C and Collagen Injection 0.5g Model NO.: SINOHM03004 Store Method: Normal Temperature Quality Guarantee Period: Two Years Certification: CE, SGS, FDA, EEC, MSDS, GMP Group: Adults Main Ingredient: Vitamin C and Collagen Function: Moisturizer, Anti-Aging, Whitening/Lightening, Anti-Wrinkle Type: Skin Care Quality Standard: Bp, USP Usage: Skin Whitening, Lightening, Anti-Aging MOQ: 100,000 Ampoules OEM Service: Available Registration Dossiers: Available Factory Inpsection: Available Sample: Available Shelf Life: 24 Months Storage: Cool and Dry Place Caution: Consult The Doctor Trademark: VICOLLA Transport Package: 5 AMPS/Tray/Box Specification: 0.5g/5ml, 1.0g/5ml Origin: France HS Code: 2934100090 Product Description PRODUCT NAME:VICOLLA® ( Vitamin C and Collagen Liquid for Injection )STRENGTH:0.5/ 1.0gPACKING DETAILS:5 Ampoules/tray/boxSTORAGE:Store in a cool and dry place below 25ºC, protected from light.SHELF LIFE:24 monthsREGISTRATION DOSSIERS ARE AVAILABLE.ConSIGNMENT MANUFACTURING, BRAND OEM/ODM SERVICE IS AVAILABLE.Platinum LaroscorbineVitamin C 10X SKIN WHITENING & LIGHTENINGCollagen ANTI-AGING PRODUCTS1. PharmacologyAscorbic acid, awater-soluble vitamin, is essential for formation of collagen and intercellular material,and therefore necessary for the development of cartilage, bone, teeth and forthe healing of wounds. It is also essential for the conversion from folic acid tofolinic acid, facilitates iron absorption from the gastro-intestinal tract and influences haemoglobin formation and erythrocyte maturation.2. IndicationsThe prevention and treatment of scurvy, or other conditions requiring vitamin Csupplementation, where the deficiency is acute or oral administration is difficult.3. DosageRoute of Administration: ParenteralAdults0.5 to 1g daily for scurvy, 200 to 500mg daily for preventative therapy.Children100 to 300mg daily for curative purposes, or 30mg daily for protective treatment.ElderlyNo special dosage requirements have been suggested.4. ContraindicationsHyperoxaluriaSpecial PrecautionsAscorbic acid should be given with care to patients with underlying renaldue to the risk of formation of renal oxalate calculi. Tolerance may be inducedin patients taking high doses.Large doses of Ascorbic Acid have resulted in haemolysis in patients withglucose -6-phosphate dehydrogenase(G6PD)deficiency.5. Undesirable effectsLarge doses may cause gastrointestinal disorders including diarrhoea. Largedoses may also result in hyperoxaluria and renal oxalate calculi may form if theurine becomes acidic. Doses of 600mg or more daily have adiuretic action.Induced tolerance with prolonged use of large doses can result in symptoms ofdeficiency when intake is reduced to normal.6. Drug InteractionsDrugs which induce tissue desaturation of ascorbic acid include aspirin,from cigarettes, alcohol, several appetite suppressants, iron phenytoin, someanti-convulsant drugs, the oestrogen component of oral contraceptives andLarge doses of ascorbic acid may cause the urine to become acidicCausing unexpected renal tubular reabsorption of acidic drugs, thus producing an exaggerated response.Conversely basic drugs may exhibit decreased reabsorption resulting in adecreased therapeutic effect. Large doses may reduce the response to oral anticoagulants.It has been reported that concurrent administration of ascorbic acid andfluphenazine has resulted in decreased fluphenazine plasma concentrations.Ascorbic acid is astrong reducing agent and interferes with numerous laboratorytests based on oxidation-reduction reactions. Specialised references should be consulted for specificinformation on laboratory test interferences caused by ascorbic acid.Ascorbic acid given in addition to desferrioxamine in patients with iron overloadto achieve better iron excretion may worsen iron toxicity, particularly to the heart,early on in the treatment when there is excessive tissue iron. Thereforeit is recommended that in patients with normal cardiac function ascorbic acidshould not be given for the first month after starting desferrioxamine.Ascorbic acid should not be given in conjunction with desferrioxamine in patientswith cardiac dysfunction.Aspirin can reduce the absorption of ascorbic acid by approximately athird anddecreases urinary excretion by about half. The clinical importance of this isuncertain.Patients with kidney failure given aluminium antacids and oral citrate can developa potentially fatal encephalopathy due to marked rise in blood aluminium levels.There is evidence that vitamin Cmay interact similarly.Oral contraceptives lower serum levels of ascorbic acid.7. Presentation-5 ampoules/tray/boxMarketing Authorisation Holder:Laboratories Viroche S.A.All Designed and formulated from FranceGlobal Supplier and Exporter:Shandong Sino Pharmaceutical Technology Co.,Ltd.North of National Road 327, Liuhang Town, High-tech Zone, Jining, China.Payment: T/T or west unionDelivery time: within 2 working days for ready stocks, 45 working days for batch order.Shipment: HKEMS,TNT,UPS,door to door service for some countries.WearelookingfortheLEVICAR®agents all around the world.Welcome to join us!Moreover, kindly note that we are always providing our customers with Consignment Manufacturing Serivce, OEM/ODM.